SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-046636
Filing Date
2012-02-08
Accepted
2012-02-08 16:27:39
Documents
9
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d293023d10q.htm 10-Q 520809
2 EX-31.1 d293023dex311.htm EX-31.1 7740
3 EX-31.2 d293023dex312.htm EX-31.2 7756
4 EX-32.1 d293023dex321.htm EX-32.1 4552
  Complete submission text file 0001193125-12-046636.txt   2077998

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT avnr-20111231.xml EX-101.INS 258142
6 XBRL TAXONOMY EXTENSION SCHEMA avnr-20111231.xsd EX-101.SCH 12935
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE avnr-20111231_cal.xml EX-101.CAL 31196
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE avnr-20111231_lab.xml EX-101.LAB 113745
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avnr-20111231_pre.xml EX-101.PRE 66697
Mailing Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656
Business Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-15803 | Film No.: 12582255
SIC: 2834 Pharmaceutical Preparations